The largest database of trusted experimental protocols

Anti cd107a mab

Manufactured by BD
Sourced in Germany

Anti-CD107a mAb is a monoclonal antibody that specifically binds to the CD107a (LAMP-1) protein. CD107a is a marker of lysosomal-associated membrane protein expression, which is commonly used to identify the degranulation of cytotoxic lymphocytes, such as natural killer cells and cytotoxic T cells.

Automatically generated - may contain errors

7 protocols using anti cd107a mab

1

Polyfunctional NK Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polyfunctional NK cells were studied with degranulation assays and the cellular production of cytokines was assessed, as previously described (18 (link)). NK cells were pretreated overnight in the presence of interleukin (IL)-12 (10 ng/mL) and IL-18 (100 ng/mL) to measure the intracellular production of IFN-γ and TNF-α by NK cells or incubated with standard HLA class 1-negative K562 target cells (ATCC CCL243) at an effector : target (E : T) cell ratio of 1 : 1 to measure degranulation in the presence of anti-CD107a mAb (#H4A3; Becton Dickinson) (Supplementary Table 1). Cells were incubated for 5 h in the presence of Golgi Stop and Golgi Plug solutions (BD Biosciences; Franklin Lakes, NJ, USA) and then stained with NK cell surface markers. NK cells were thereafter fixed, permeabilized with a Cytofix/Cytoperm kit (Becton Dickinson; Franklin Lakes, NJ, USA), and then intracellularly stained with anti-IFN-γ and anti-TNF-α mAbs (Supplementary Table 1), as described previously (18 (link)). Only samples containing at least 100 CD3CD56+ NK cells were acquired on a DXFlex flow cytometer and then analyzed with FlowJo version 10; consequently, the number of samples may vary depending on the experiments.
+ Open protocol
+ Expand
2

Phenotyping and Functional Analysis of NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cell lines from the 3 characterized healthy donors were incubated with peptide-pulse HLA-transfected 721.221-ICP47 cells at an effector:target (E:T) cell ratio of 1:1, in the presence of anti-CD107a mAb (#H4A3; Becton Dickinson) to measure degranulation. Cells were thereafter incubated for 5 h in the presence of Golgi Stop and Golgi Plug solutions (BD Biosciences) and then stained with cell-surface markers (anti-CD3, anti-CD56, and anti-CD45). Cells were fixed, permeabilized with a cytofix/cytoperm kit (Becton Dickinson), and then intracellularly stained with anti-IFN-γ (#B27; Becton Dickinson) and anti-TNF-α (#Mab11; eBiosciences), as previously described [31 ]. Data were analyzed with the “Boolean gate” algorithm using Flow Jo version 9 (TreeStar). Pestle software was used to remove the background, and pie charts, generated with Spice software (NIAI freeware) [32 (link)], present the frequency of NK cells positive for 0, 1, 2, or 3 responses. Arcs depict the frequency of cells positive for CD107a, IFN-γ, or TNF-α.
+ Open protocol
+ Expand
3

Measuring NK Cell Activation and Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
NK cells were pre-treated overnight in the presence of interleukin (IL)-12 (10 ng/ml) plus IL-18 (100 ng/ml) to measure the intracellular production of IFN-γ and TNF-α by NK cells, or incubated with the standard HLA class-1 negative K562 target cells (ATCC CCL243), at an effector:target (E:T) cell ratio of 1:1, to measure degranulation in the presence of anti-CD107a mAb (#H4A3; Becton Dickinson) (Supplementary Table 1). Cells were thereafter incubated for 5 hours in the presence of Golgi Stop and Golgi Plug solutions (BD Biosciences) and then stained with NK cell-surface markers. Next, NK cells were fixed, permeabilized with a cytofix/cytoperm kit (Becton Dickinson) and then intracellularly stained with anti-IFN-γ and anti-TNF-α mAbs (Supplementary Table 1), as previously described (Carbonnel et al., 2022 (link)). At least 1000 CD3-CD56+ NK cells were acquired on a Gallios flow cytometer (Beckman Coulter) and then analyzed with Flow Jo version 10 (TreeStar, state).
+ Open protocol
+ Expand
4

Cytotoxicity Assay of iNK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iNK cells were stimulated using K562-cell line at 10:1 E/T ratio in precursor complete medium. Anti-CD107a mAb (BD pharmingen) was added after 1 h. After 4 h of stimulation, cells were surface-stained using PC5-conjugated anti-CD56 and FITC-conjugated anti-CD3 (ref. 32 (link)).
+ Open protocol
+ Expand
5

MAIT Cell Stimulation and Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
MAIT cells in the PBMC samples were stimulated for 24 h with Escherichia coli strain D21 (ratio E. coli CFU: PBMC of 3:1) or with a combination of IL-12p70 (10 ng/mL, Peprotech) and IL-18 (100 ng/mL, Medical & Biological Laboratories). E. coli was mildly fixed in formaldehyde prior to addition to PBMCs as previously described.33 (link) To assess degranulation, anti-CD107a mAb (BD Biosciences) was added at the beginning of the assay. In the E. coli-mediated stimulation assays, anti-MR1 mAb (clone 26.5, Biolegend) or IgG2a isotype control (clone MOPC-173, Biolegend) was added at the beginning of the assay at the final concentration of 20 μg/mL. Monensin (Golgi Stop, BD Biosciences) and brefeldin A (Golgi Plug, BD Biosciences) were added for the last 6 h of the experiment. In selected experiments, viability of MAIT cells in PBMC samples was assessed by annexin V (AnnV) and dead cell marker (DCM) staining ex vivo or in vitro following either five-day incubation of PBMCs with IL-12 p70 (10 ng/mL) and IL-18 (100 ng/mL) or 24 h incubation with supernatants (pure or at different dilutions) from HDV-infected or uninfected HepG2hNTCP cells.
+ Open protocol
+ Expand
6

Reverse ADCC Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC were cocultured with target cell lines at a 1:1 E:T ratio in complete medium. For reverse-ADCC, cells were challenged using FcγR+ P815 target cells at 1:1 E:T ratio in complete medium in the absence or presence of PMA+Ionomycin. Anti-CD107a mAb (BD PharMingen) was added, as previously described [29 (link)]. Cells were surface-stained using anti-CD3FITC and anti-CD56PeCy7 mAbs.
+ Open protocol
+ Expand
7

NK Cell Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxic activity of NK cells was assessed in a CD107a degranulation assay as described before [15 (link)]. In brief, pre-activated PBMC were co-cultured with primary HSC in the presence of anti-CD107a mAb for 1h (BD, Heidelberg, Germany). Then, GolgiStop (1:100; BD, Heidelberg, Germany) was added and cells were co-cultured for an additional 4h. For detection of surface proteins cells were stained with anti-CD56, anti-CD16, anti-CD3 mAbs (all from Biolegend, USA) and fixed using Cellfix solution (BD Biosciences, Germany). Viability staining was performed by Zombie Aqua Fixable Viability Kit. Cell analysis was performed by flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!